NCT05803785View on ClinicalTrials.gov

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

BBC1501

BBC1501 solution for Intravitreal injection

Trial Locations (2)

2000

NOT_YET_RECRUITING

Benobio Investigational site, Sydney

Unknown

RECRUITING

Sydney Hospital, Sydney

All Listed Sponsors
lead

Benobio Co., Ltd.

INDUSTRY